Echo Therapeutics is focused on medical devices. Echo is developing the Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system for patients with diabetes and for use in hospital critical care units. Echo is also developing its needle-free Prelude™ SkinPrep System for transdermal drug delivery of a wide range of novel topical reformulations of widely-used, FDA-approved products.
Specialties
transdermal drug delivery, continuous glucose monitoring, medical devices
New hires at Echo Therapeutics
-
Director, Human Resources
Came from...
Field Diagnostics, Director, Human Resources
-
